News chronological

Showing 10 items before 1080520

THENATIONALPULSE (Pulse Wires) - Senate Advances DHS, ICE Funding in Narrow 50-48 Vote.

The Senate narrowly passed a $70 billion budget plan to fund U.S. Immigration and Customs Enforcement (ICE) and Border Patrol, advancing efforts to end the Department of Homeland Security's partial shutdown.

The Senate narrowly passed a $70 billion budget plan to fund U.S. Immigration and Customs Enforcement (ICE) and Border Patrol, advancing efforts to end the Department of Homeland Security’s partial shutdown . PULSE POINTS WHAT HAPPENED: The Senate passed a $70 billion budget plan for U.S. Immigration and Customs Enforcement (ICE) and Border Patrol in a 50-48 vote, aiming to end a partial government shutdown at the Department of Homeland Security (DHS). The bill, advanced through reconciliation to bypass the filibuster, now heads to the House for further consideration. DETAIL: The budget plan includes funding for ICE and Border Patrol through the end of President Donald J. Trump’s term. The vote took place at 3:30 AM on Thursday,…Open

THEAMERICANCONSERVATIVE (Joseph Addington) - U.S. Reclassifies State-Licensed Marijuana

State of the Union: The drug’s new classification as a Schedule III controlled substance will facilitate its use in medical research. The post U.S. Reclassifies State-Licensed Marijuana appeared first on The American Conservative .

Acting Attorney General Todd Blanche announced Thursday that the Justice Department has reclassified “FDA-approved marijuana and state-licensed marijuana” from Schedule I controlled substances to Schedule III controlled substances. The move, which does not legalize marijuana, will facilitate the use of the drug in medical research. Schedule III substances are still subject to numerous legal restrictions, including on transportation across state lines. Blanche also announced that the Justice Department would hold expedited hearings to reschedule marijuana as a whole. The reclassification fulfills an executive order signed by President Donald Trump in December 2025 directing the administration to move the drug to the less restrictive…Open